Comment on Gautheret‐Dejean et al.: Performance of rapid tests for discrimination between HIV‐1 and/or HIV‐2 infections

Bo Langhoff Honge,* Sanne Jespersen, Delfim Vicente Mendes, Christian Wejse, and Christian Erikstrup Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark GloHAU, Center of Global Health, School of Public Health, Aarhus University, Aarhus, Denmark

[1]  S. Brunet,et al.  Performance of rapid tests for discrimination between HIV‐1 and/or HIV‐2 infections , 2015, Journal of medical virology.

[2]  C. Wejse,et al.  Cohort Profile: The Bissau HIV Cohort-a cohort of HIV-1, HIV-2 and co-infected patients. , 2015, International journal of epidemiology.

[3]  C. Wejse,et al.  Challenges facing HIV treatment in Guinea-Bissau: the benefits of international research collaborations , 2014, Bulletin of the World Health Organization.

[4]  D. Minta,et al.  Re-testing and misclassification of HIV-2 and HIV-1&2 dually reactive patients among the HIV-2 cohort of The West African Database to evaluate AIDS collaboration , 2014, Journal of the International AIDS Society.

[5]  C. Wejse,et al.  Performance of 3 Rapid Tests for Discrimination Between HIV-1 and HIV-2 in Guinea-Bissau, West Africa , 2014, Journal of acquired immune deficiency syndromes.

[6]  T. de Oliveira,et al.  High level of HIV‐2 false positivity in KwaZulu‐Natal province: A region of South Africa with a very high HIV‐1 subtype C prevalence , 2013, Journal of medical virology.

[7]  R. Zachariah,et al.  Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  A. Rodrigues,et al.  Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? , 2008, AIDS.